As biotechnology innovations move from laboratory research toward commercialization, companies and inventors often find themselves navigating complex patent issues involving composition claims, method claims, freedom to operate, and competitive risk.
If you are developing biotechnology products, your intellectual property strategy will determine whether your product reaches the market, how long it remains exclusive, and how much value it generates over its commercial lifecycle.
NK Patent Law represents biotechnology companies in patent prosecution and intellectual property strategy. Because patent law is federal, we represent clients regardless of location, including U.S. counsel work coordinated with global filing strategies.
Our team has secured 2,100+ issued patents and 1,000+ registered trademarks for clients across technology areas including chemistry, biotechnology, and life sciences. Our work in biotechnology and related technical fields informs our approach to IP strategy.
Call (919) 348-2194 or contact NK Patent Law to discuss your biotech patent strategy.
Representative Experience
- Patent prosecution for small molecule compositions, including polymorphs and salt forms.
- Patent protection for antibody and therapeutic protein inventions.
- Patent prosecution for fusion proteins and peptide therapeutics.
- Patent strategy for process chemistry, synthesis routes, and manufacturing intermediates.
- Freedom-to-operate analyses for life sciences clients across composition, method, and formulation claims.
- Patent due diligence for biotechnology acquisitions, licensing, and financings.
- International patent filings coordinated across PCT and foreign jurisdictions for life sciences portfolios.
Patent protection across biotechnology
We assist clients with patents directed to:
- Small molecules and new chemical entities — composition of matter, polymorphs, and salts
- Biologics — antibodies, therapeutic proteins, fusion proteins, peptide therapeutics
- Process chemistry — synthesis routes, manufacturing methods, intermediates
Biotechnology patent prosecution requires drafting claims that survive examination under Sections 101, 102, 103, and 112 while providing meaningful protection competitors cannot easily design around.
Why NK Patent Law
NK Patent Law is your partner on your AI journey to accelerate innovation, optimize operations, and gain a competitive edge.
Freedom to operate and competitive analysis
Before launching a biotec product, expanding into a new indication, or completing a financing round, companies need clear visibility into third-party patent risk.
Our FTO work for life sciences clients includes:
- Identifying relevant competitor patents across composition, method, and formulation claims
- Analyzing claim scope relative to the product and intended use
- Assessing infringement risk and design-around opportunities
- Coordinating with regulatory strategy where claim scope intersects with labeling
In crowded areas, FTO analysis directly informs both business decisions and valuation.
Licensing, due diligence, and transactions
IP is central to most life sciences transactions.
We assist clients with:
- Patent due diligence for acquisitions, licensing, and financings
- Evaluation of in-licensed and out-licensed portfolios
- Patent and regulatory exclusivity considerations in deal structuring
- Identifying ownership, prosecution history, and FTO issues that affect value
Diligence findings in transactions often hinge on whether claim scope actually covers the approved or planned product.
Additional Practice Areas
Put us to work and start harnessing the power of your intellectual property.
Contact us today to learn more.
Technical backgrounds
Our attorneys and patent agents working on life sciences matters bring backgrounds in chemistry, biotechnology, and related technical fields.
This technical foundation allows us to engage directly with scientific teams, translate development work into patentable subject matter, and draft claims that reflect both the underlying science and the business objectives.
Why biotech companies choose NK Patent Law
Choosing the right patent counsel for biotech work directly affects the strength and value of your IP position.
Clients choose NK Patent Law because:
- We focus on patent prosecution and IP strategy as our core practice
- We provide business-partner-level attention from experienced attorneys
- We approach IP strategy in the context of regulatory and commercial realities
- We offer sophisticated IP counsel without large-firm pricing structure
- We work with companies from early development through commercialization and lifecycle management
NK Patent Law has been recognized by Legal 500 U.S. Elite, Best Lawyers in America for Intellectual Property, Business North Carolina Legal Elite, and the Chambers USA Regional Spotlight Guide.
Speak with biotech patent counsel
If you are evaluating a patent portfolio for a transaction, facing competition, or building a long-term lifecycle strategy, the timing and quality of your IP work matters.
Call NK Patent Law at (919) 348-2194 or contact us online to discuss your biotechnology patent strategy.